← Back to Analyst Consensus 
USNA Hold
USANA HEALTH SCIENCES INC
Current Price —
Implied Upside —
Analysts 6
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Feb 27, 2025 | DA Davidson | maintain | Neutral → Neutral | $36 | 55% |
| Jan 2, 2025 | DA Davidson | maintain | Neutral → Neutral | $38 | 55% |
| Oct 23, 2024 | DA Davidson | maintain | Neutral → Neutral | $35 | 55% |
| Jul 25, 2024 | DA Davidson | maintain | Neutral → Neutral | $38 | 55% |
| May 7, 2024 | DA Davidson | maintain | Neutral → Neutral | $46 | 55% |
| Feb 22, 2024 | DA Davidson | maintain | Neutral → Neutral | $48 | 55% |
| Oct 25, 2023 | DA Davidson | maintain | Neutral → Neutral | $53 | 55% |
| Apr 26, 2023 | DA Davidson | maintain | — → Neutral | $56 | 55% |
| Feb 13, 2023 | DA Davidson | maintain | — → Neutral | $52.5 | 55% |
| Oct 27, 2022 | DA Davidson | maintain | — → Neutral | $49 | 55% |
| Jul 28, 2022 | DA Davidson | maintain | — → Neutral | $57 | 55% |
| Jul 12, 2022 | DA Davidson | maintain | — → Neutral | $58 | 55% |
| Jul 7, 2022 | Jefferies | downgrade | Hold → Underperform | $53 | 52% |
| Apr 27, 2022 | DA Davidson | maintain | — → Neutral | $76 | 55% |
| Apr 14, 2022 | DA Davidson | initiate | — → Neutral | $86 | 55% |
| Feb 10, 2021 | Roth Capital | maintain | — → Buy | $126 | 53% |
| Dec 17, 2020 | Roth Capital | initiate | — → Buy | $107 | 53% |
| Aug 22, 2019 | Jefferies | initiate | — → Hold | $65 | 52% |
| Jul 3, 2019 | Sidoti & Co. | downgrade | Buy → Neutral | $70 | 40% |
| Apr 16, 2019 | Tigress Financial | initiate | — → Buy | $0 | 55% |
| Apr 23, 2018 | Pivotal Research | downgrade | Buy → Hold | $0 | 73% |
| Jan 24, 2018 | Sidoti & Co. | downgrade | Buy → Neutral | $0 | 40% |
| May 3, 2017 | Pivotal Research | upgrade | Hold → Buy | $0 | 73% |
| May 1, 2017 | Pivotal Research | downgrade | Buy → Hold | $0 | 73% |
| Feb 10, 2016 | DA Davidson | downgrade | Buy → Neutral | $0 | 55% |
| Sep 16, 2015 | DA Davidson | upgrade | Neutral → Buy | $165 | 55% |
| Aug 6, 2015 | DA Davidson | downgrade | Buy → Neutral | $180 | 55% |
| Jun 26, 2015 | DA Davidson | initiate | — → Buy | $165 | 55% |
| Apr 27, 2015 | Pivotal Research | downgrade | Buy → — | $135 | 73% |
| Oct 20, 2014 | Pivotal Research | initiate | — → Buy | $100 | 73% |
| Oct 17, 2014 | Canaccord Genuity | maintain | — → Hold | $78 | 48% |
| Nov 8, 2013 | Sidoti & Co. | upgrade | Neutral → Buy | $92 | 40% |
| Jul 24, 2013 | DA Davidson | maintain | — → Neutral | $92 | 55% |
| May 30, 2013 | DA Davidson | downgrade | Buy → Neutral | $0 | 55% |
| Feb 7, 2013 | Wedbush | upgrade | Underperform → Neutral | $40 | 58% |
| Dec 17, 2012 | Canaccord Genuity | downgrade | Buy → Hold | $40 | 48% |
| Oct 24, 2012 | Wedbush | maintain | — → Underperform | $40 | 58% |
| Oct 24, 2012 | DA Davidson | maintain | — → Buy | $80 | 55% |
| Jul 31, 2012 | Canaccord Genuity | upgrade | Hold → Buy | $60 | 48% |
| Apr 24, 2012 | DA Davidson | maintain | — → Buy | $51 | 55% |
Price Target Trend
Apr 27, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days